Skip to main content
. 2019 Jun 7;16(11):2032. doi: 10.3390/ijerph16112032

Table 1.

Demographic, drug use and service utilization characteristics of survey participants and non-participants.

Characteristic Survey Participants
n = 182
% (n/N)
Non-Participants
n = 318
% (n/N)
Gender
  Female 29 (53) 24 (77)
  Male 69 (126) 74 (235)
  Transgender 1 (3) 2 (5)
  Not stated 0 (0) <1 (2)
Age, in years—median (mean; SD) 42 (43.0; 9.0) 43 (42.6; 6.9)
Aboriginality
  Neither Aboriginal nor Torres Strait Islander 78 (141) 73 (232)
  Aboriginal and/or Torres Strait Islander 17 (31) 16 (50)
  Did not specify 2 (3) 1 (3)
  Missing 4 (7) 10 (31)
Other characteristics (assessed at initial visit)
  Stable accommodation 60 (92/153) 67 (86/172)
  Employed 20 (35/174) 22 (63/288)
  Ever in drug treatment 61 (111/182) 59 (188/318)
  Ever in prison 45 (77/94) 41 (117/284)
  Ever overdosed 38 (64/169) 39 (108/278)
  Health issue 36 (52/143) 29 (67/229)
  Injected drugs daily * 55 (94/171) 45 (124/277)
  Client of local primary health care service ** 33 (60/182) 23 (74/318)
Drug used most (assessed in the 8 months before survey) a
  Heroin 54 52
  Oxycodone 5 5
  Buprenorphine ** 8 3
  Methadone 6 8
  Morphine 6 6
  Cocaine 4 2
  Methamphetamine 31 40
Service use—median (mean; SD)
  Number of visits since initial visit *** 313 (796.2; 1308.6) 97 (406.2; 811.6)
  Number of visits during survey period *** 5 (9.0; 10.4) 2 (2.9; 3.9)
Number of referrals in the past 12 months *** 1 (2.0; 2.7) 0 (0.6; 1.4)
Number of years since initial visit ** 10.5 (9.4; 8.5) 8.3 (8.2; 7.6)
Age in years when first injected 18 (19.3; 6.9) 18 (19.6; 7.0)

a Among drugs listed; * p < 0.05; ** p < 0.01; *** p < 0.001.